Found: 17
Select item for more details and to access through your institution.
NOTCH2 Is Neither Rearranged nor Mutated in t(1;19) Positive Oligodendrogliomas.
- Published in:
- PLoS ONE, 2009, v. 4, n. 1, p. 1, doi. 10.1371/journal.pone.0004107
- By:
- Publication type:
- Article
Erratum to: Development and validation of the FRAGIRE tool for assessment an older person's risk for frailty.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development and validation of the FRAGIRE tool for assessment an older person's risk for frailty.
- Published in:
- BMC Geriatrics, 2016, v. 16, p. 1, doi. 10.1186/s12877-016-0360-9
- By:
- Publication type:
- Article
Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression.
- Published in:
- European Journal of Human Genetics, 2010, v. 18, n. 5, p. 560, doi. 10.1038/ejhg.2009.230
- By:
- Publication type:
- Article
Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil ( ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 5, p. 721, doi. 10.1002/cam4.408
- By:
- Publication type:
- Article
Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 3, p. 153, doi. 10.1177/1758834015572343
- By:
- Publication type:
- Article
Identification of limited regions of genetic aberrations in patients affected with Wilms' tumor using a tiling-path chromosome 22 array.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 3, p. 571, doi. 10.1002/ijc.21868
- By:
- Publication type:
- Article
Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 5, p. 1159, doi. 10.1002/ijc.21385
- By:
- Publication type:
- Article
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Understanding the Prognostic Value of Primary Tumor Location and KRAS in Metastatic Colorectal Cancer: A Post Hoc Analysis of the OPTIMOX3 DREAM Phase III Study.
- Published in:
- Clinical Colorectal Cancer, 2020, v. 19, n. 3, p. 200, doi. 10.1016/j.clcc.2020.02.012
- By:
- Publication type:
- Article
Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2006, v. 45, n. 7, p. 656, doi. 10.1002/gcc.20331
- By:
- Publication type:
- Article
Chromosome 22 tiling‐path array–CGH analysis identifies germ‐line‐ and tumor‐specific aberrations in patients with glioblastoma multiforme.
- Published in:
- Genes, Chromosomes & Cancer, 2005, v. 44, n. 2, p. 161
- By:
- Publication type:
- Article
High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.
- Published in:
- Genes, Chromosomes & Cancer, 2005, v. 42, n. 3, p. 228
- By:
- Publication type:
- Article
A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications.
- Published in:
- Human Molecular Genetics, 2002, v. 11, n. 25, p. 3221, doi. 10.1093/hmg/11.25.3221
- By:
- Publication type:
- Article
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1503-7
- By:
- Publication type:
- Article
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 496, doi. 10.1186/s12885-015-1503-7
- By:
- Publication type:
- Article
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article